Form 4: CODX CEO Granted 275,000 Restricted Stock Units

Co-Diagnostics, Inc. CEO Dwight H. Egan was granted 275,000 Restricted Stock Units, aligning executive compensation with long-term shareholder value.

Summary

• Dwight H. Egan, Chief Executive Officer and Director of Co-Diagnostics, Inc. (CODX), was granted 275,000 Restricted Stock Units (RSUs).
• The grant date for these RSUs was August 13, 2025.
• Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting.
• The RSUs were granted under the Issuer's 2015 Long Term Incentive Plan, as amended.
• Following this transaction, Mr. Egan beneficially owns 575,833 securities, comprising 300,833 shares of Common Stock and 275,000 Restricted Stock Units.

Sentiment

Score: 7

Explanation: The grant of Restricted Stock Units to the CEO is generally a positive sign as it aligns executive incentives with long-term shareholder value, promoting retention and performance tied to stock appreciation. It's a standard compensation practice.

Positives

• The grant of 275,000 Restricted Stock Units to the CEO aligns management's long-term interests with those of shareholders.
• The use of a long-term incentive plan (2015 Long Term Incentive Plan) demonstrates a structured approach to executive compensation.

Negatives

• No immediate cash compensation is provided to the executive through this RSU grant.

Stakeholder Impact

• Shareholders: Potential for increased alignment between executive performance and shareholder returns due to equity-based compensation.
• Employees: May signal stability in executive leadership and a commitment to long-term growth.

Next Steps

• RSUs will vest in 6 installments, commencing on November 23, 2025, and continuing every 6 months thereafter.

Key Dates

Keywords

Co-Diagnostics, CODX, Dwight H. Egan, Restricted Stock Units, RSU, Executive Compensation, Insider Transaction, Form 4, Equity Grant, Long Term Incentive Plan